期刊文献+

环氧合酶-2对酒精性肝损伤大鼠氧化/抗氧化的作用 被引量:2

下载PDF
导出
摘要 目的:探讨环氧合酶(COX)-2抑制剂对酒精诱导的肝损伤大鼠氧化/抗氧化系统的作用. 方法:应用酒精灌胃法制作酒精性肝损伤大鼠模型,对照组(n=10)玉米油+葡萄糖;损伤组(n=24)酒精+玉米油;处理组(n=24)在损伤组基础上予选择性COX-2抑制剂塞莱昔布(celecoxib).23 d后处死大鼠,测定血浆和肝组织匀浆谷胱甘肽-S转移酶(GST)活性、超氧化歧化酶(SOD)活性和丙二醛(MDA)水平,血清门冬氨酸氨基转移酶(AST)和丙氨酸氨基转移酶(ALT)水平,Western blot法检测各组大鼠肝组织中COX-2蛋白的表达. 结果:与对照组相比,损伤组中血清AST、ALT、血浆GST活性和肝组织MDA水平明显升高(196.00±29.52 vs 139.78±26.27.59.43±6.00 vs 46.67±10.09,17.56±1.26 vs 13.29±4.31,0.562±0.054 vs 0.465±0.062,P<0.01或P<0.05),血浆及肝组织SOD活性、肝组织GST活性明显下降(43.969±8.863 vs 57.788±7.587,2.083±0.394 vs 2.943±0.321.1.63±0.64 vs 3.54±0.33,P<0.01).与对损伤相比,处理组血清AST明显下降、血浆及肝组织SOD 活性、肝组织GST活性均明显升高(144.00±18.45 vs 196.00±29.52.55.547±5.937 vs 43.969±8.863,2.833±0.176 vs 2.083±0.394,3.77±0.32 vs 1.63±0.64,P<0.01). Western blot显示,肝组织中COX-2表达损伤组较对照组明显升高(0.5 239±0.1 399 vs 0.2 255±0.0 916,P<0.01), 处理组较损伤组降低,而较对照组升高(0.3 769±0.1 798 vs 0.5 239±0.1 399,0.3 769±0.1 798 vs 0.2 255±0.0 916, P<0.05). 结论:COX-2的表达与酒精性肝损伤大鼠肝组织抗氧化酶系呈负相关而与脂质过氧化(lipid peroxides,LPO)产物正相关,其抑制剂则可以使酒精性肝损伤大鼠肝组织抗氧化酶系活性升高和LPO减轻,从而对大鼠酒精诱导的肝损伤起保护作用.
出处 《世界华人消化杂志》 CAS 2004年第8期1934-1936,共3页 World Chinese Journal of Digestology
  • 相关文献

参考文献13

  • 1Okamoto T, Hino O. Expression of cyclooxygenase-1 and -2 mRNA in rat tissues: tissue-specific difference in the expression of the basal level of mRNA. Int J Mol Med 2000;6:455-457.
  • 2吴汉平,吴开春,李玲,幺立萍,兰梅,王新,樊代明.人环氧合酶-2(hCOX-2)编码基因的克隆及其反义核酸转染胃癌细胞的初步研究[J].世界华人消化杂志,2000,8(11):1211-1217. 被引量:35
  • 3刘建平,朱兆华.大肠肿瘤COX-2的表达与临床病理特征的关系[J].世界华人消化杂志,2003,11(3):306-309. 被引量:6
  • 4Nanji AA, Jokelainen K, Fotouhinia M, Rahemtulla A, Thomas P, Tipoe GL, Su GL, Dannenberg AJ. Increased severity of alcoholic liver injury in female rats: role of oxidative stress,endotoxin, and chemokines. Am J Physiol Gastrointest Liver Phusiol 2001;281:G1348-G1356.
  • 5Tsukamoto H, Lu SC. Current concepts in the pathogenesis of alcoholic liver injury. FASEB J 2001;15:1335-1349.
  • 6Kanbagli O, Balkan J', Aykac-Toker G, Uysal M. Hepatic mitochondrial prooxidant and antioxidant status in ethanol-induced liver injury in rats. Biol Pharm Bull 2002;25:1482-1484.
  • 7Mottaran E, Stewart SF, Rolla R, Vay D, Cipriani V, Moretti M, Vidali M, Sartori M, Rigamonti C, Day CP, Albano E.Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease. Free Radic Biol Med 2002;32:38-45.
  • 8Wheeler MD, Nakagami M, Bradford BU, Uesugi T, Mason RP, Connor HD, Dikalova A, Kadiiska M, Thurman RG.Overexpression of manganese superoxide dismutase prevents alcohol-induced liver injury in the rat. J Biol Chem 2001;276:36664-36672.
  • 9陈文慧,刘平,徐光福,陆雄,熊卫国,李风华,刘成海.脂质过氧化在二甲基亚硝胺大鼠肝纤维化形成过程中的作用[J].世界华人消化杂志,2001,9(6):645-648. 被引量:43
  • 10Degoul F, Sutton A, Mansouri A, Cepanec C, Degott C,Fromenty B, Beaugrand M, Valla D, Pessayre D. Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease.Gastroenterology 2001;120:1468-1474.

二级参考文献62

  • 1Yun-Lin Wu~1 Bo Sun~1 Xue-Jun Zhang~2 Sheng-Nian Wang~2 Heng-Yi He~2 Min-Min Qiao~1 Jie Zhong~1 Jia-Yu Xu~1 1 Department of Gastroenterology,Ruijin Hospital,Shanghai Second Medical University,Shanghai 200025,China2 Institude of Biochemistry and Cell Biology,Shanghai Institues for Biological Sciences,Chinese Academy of Sciences.Shanghai 200025,China.Growth inhibition and apoptosis induction Sulindac on Human gastric cancer cells[J].World Journal of Gastroenterology,2001,7(6):796-800. 被引量:64
  • 2赖鼎元.青年人胃癌46例与中老年胃癌对比分析[J].新消化病学杂志,1994,2(2):86-87. 被引量:7
  • 3[1]Ramm GA, Carr SC, Bridle KR, Li L, Britton RS, Crawford DH, Vogler CA,Bacon BR, Tracy TF. Morphology of liver repair following cholestatic liver injury:resolution of ductal hyperplasia, matrix deposition and regression of myofibroblasts. Liver, 2000;20:387- 396
  • 4[2]Kapoor D, Kumar N. Hepatic fibrosis: pathobiology and management. Trop Gastroenterol, 2000;21:114 - 117
  • 5[3]Ala-Kokko L, Pihlajaemi T, Myers J. Gene expressions of type Ⅰ, Ⅲ and Ⅳ collagens in hepatic fibrosis induced by dimethylnitrosamine in the rat. Biochen J,1987;244:75-79
  • 6[4]Casu A, Canepa M, Nanni G. Perisinusoidal stellate cells or Ito cells and their role in hepatic fibrosis. Pathologica, 1994;86:467-499,410
  • 7[5]Friedman SL. Molecular mechanisms of hepatic fibrosis and principles of therapy.J Gastroenterol, 1997; 32: 424 - 430
  • 8[6]Wu J, Zern MA. Hepatic stellate cells: a target for the treatment of liver fibrosis.J Gastroenterol, 2000; 35: 665 - 672
  • 9[7]Davis BH, Rapp UR, Davidson NO. Retinoic acid and transforming growth factor beta differentially inhibit platelet-derived-growth-factor-induced Ito-cell activation.Biochem J, 1991; 278 (Pt 1 ): 43 - 47
  • 10[8]Tsukamoto H. Cytokine regulation of hepatic stellate cells in liver fibrosis. Alcohol Clin Exp Res, 1999; 23: 911 - 916

共引文献137

同被引文献64

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部